Food and Drug Administration
Transmissible Spongiform Encephalopathies Advisory Committee
June 26, 2002
Briefing Information
Issue Summary - Topic #1
Validation of Procedures to Prevent Contamination and Cross-Contamination with TSE Agents of Human Tissue Intended for Transplantation doc pdf ppt
FDA Draft Guidance on Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Human Cells, Tissues, and Cellular and Tissue-Based Products doc pdf
Limiting Batch Size: Effects of Batch Size on Risk of Contamination with Infectious Agents, Dr. Thomas Lynch, PhD, Clearant, Inc. doc pdf
Topic #2
Draft Issue Summary: FDA Draft Guidance on Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Human Cells, Tissues, and Cellular and Tissue-Based Products doc pdf